WRLD A.LIVE

22:003 reports

• Cell-level analysis reveals how ovarian tumors may develop resistance to chemotherapy Medical Xpress
• How zombie cancer cells evade chemotherapy’s effects Chemical & Engineering News
• Scalp Swelling Caused by Extracranial Extension of Meningioma Cureus

21:002 reports

• Preclinical research shows macrophages can be programmed to fight solid cancer tumors Medical Xpress
• Overcoming cancer stigma requires policy changes and public education News-Medical

20:003 reports

• Clinical Scenario 2, Discussion of Treatment Goals, AUGMENT-101, and Antifungal Selection in Relapsed KMT2A-Rearranged AML CancerNetwork
• She took birth control for acne. It started ‘feeding’ a hidden cancer USA Today
• Fighting cancer also means fighting against social stigma Medical Xpress

19:001 report

• Discovery Of Potential New Vehicle For Cancer Spread Mirage News

18:008 reports

• Fewer low-risk prostate cancers treated as active surveillance becomes the norm Bioengineer.org
• Active surveillance used as less invasive prostate cancer option WRGB
• How has the treatment of low-risk prostate cancer evolved in the US? Oncology Central
• Radiotherapy Highlights Local Risks in Bile Duct Cancer EMJ
• Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal The Manila Times
• Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA News-Medical
• EMT2 trial reports higher survival with high-dose EPA UA.NEWS
• Can Omega-3 Supplements Prolong Life in Metastatic CRC? Medscape

17:002 reports

• Do Home Radon Levels Affect Risk for Brain Cancer? Medscape
• Study Reveals How Tumors Invade and Grow in the Brain Technology Networks

16:001 report

• New Tissue Atlas Will Help AI Understand Cancer Mirage News

15:00nothing heard

14:00nothing heard

13:00nothing heard

12:00nothing heard

11:001 report

• US develops chip to assess response to childhood leukemia treatment — News-Medical UA.NEWS

10:001 report

• Lab-on-a-chip technology helps predict childhood leukemia treatment responses News-Medical

09:00nothing heard

08:00nothing heard

07:001 report

• Guideline on shorter-course radiation therapy for localized prostate cancer updated Medical Xpress

06:002 reports

• Virtual Tumor Models Reveal Promising Treatment Strategies for Triple-Negative Breast Cancer Inside Precision Medicine
• ESMO 2026: RADIAN Trial Reports Improved Disease-Free Survival With Niraparib, Dostarlimab and Chemoradiotherapy in Locally Advanced Head and Neck Cancer Oncodaily

05:001 report

• Glioblastoma's secret weapon: Silencing the brain's off switch Medical Xpress

04:001 report

• Updated ASTRO guidelines recommend shorter radiation courses for prostate cancer News-Medical

03:003 reports

• AstraZeneca may start work on cancer vaccines, CEO says By Investing.com Investing.com South Africa
• AstraZeneca might develop cancer vaccines, CEO Pascal Soriot says Quartz
• AstraZeneca May Enter Cancer Vaccine Development, CEO Says Bloomberg.com

02:002 reports

• GORTEC IDEAL Trial Reports Encouraging Early Safety Results With EGFR-Targeted ADC and Immunotherapy in Head and Neck Cancer Oncodaily
• Baylor researchers discover how glioblastoma hijacks nearby brain cells News-Medical

01:002 reports

• Blocking cellular communication reduces the spread of deadly glioblastoma News-Medical
• Cisplatin-Free Pembrolizumab Regimen Misses Primary End Point in SMART-KEY CancerNetwork

00:008 reports

• Scrotal Skin Cancer Incidence Rises in US Medscape
• Bispecific Immunotherapy Shows Early Activity in Treatment-Resistant Solid Tumors Inside Precision Medicine
• ESMO 2026: Marengo’s bispecific antibody shrinks 8 tumor types in Phase 2 BioSpace
• Humaid Al-Shamsi։ First-in-Human Results Presented for Novel T-Cell Therapy in Advanced Solid Tumors Oncodaily
• A precision T-cell therapy stalls treatment-resistant cancers in clinical trial National Institutes of Health (NIH) | (.gov)
• Experimental T-cell therapy shows promise against treatment-resistant cancers Open Access Government
• Liquid Biopsy Market to Reach USD 29.2 Billion by 2036, Driven openPR.com
• Liquid Biopsy Cancer Screening Faces a Steep Climb From Lab Promise to Clinical Proof Bioengineer.org